References
- Withering W. An account of the foxglove and some of its medical uses, with practical remarks on dropsy and other diseases. In: Willis FA, Keys TE, eds. Classics of cardiology. New York: Henry Schuman 1941: 231
- Cohn JN. Unloading the heart in congestive heart failure. Am J Med 1984:77(2A): 67–70
- Chatterjee K, Ports TA, Brandage BH, et al. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. Ann Intern Med 1980: 92(5): 600–4
- Franciosa JA, Weber KT, Levine TB, et al. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J 1982:104(3): 587–94
- Packer M, Heller J, Medina N, et al. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure. N Engl J Med 1982:306(2): 57–62
- Cohn JN. Nitrates for congestive heart failure. Am J Cardiol 1985: 56(2): 19–23A
- Franciosa JA, Cohn JN. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 1980: 45(3): 648–54
- Guiha NH, Cohn JN, Mikulic E, et al. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 1974: 291(12): 587–92
- Awan NA. Miller RR, DeMaria AN, et al. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure: concomitant relief of pulmonary congestion and elevation of pump output demonstrated by Improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Circulation 1977: 56(3): 346–54
- Packer M, Meller J, Gorlin R, et al. Hemodynamic and clinical tachyphylaxis to prazosin-medlated afterload reduction in severe chronic congestive heart failure. Circulation 1979: 59(3): 531–9
- Chatteijee K, Parmley WW, Cohn JN, et al. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response. Am Heart J 1985: 110(2): 439–47
- Sharpe DN, Murphy J, Coxon R, et al. Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study. Circulation 1984:70(2): 271–8
- Walsh RW, Porter CB, Starling MR, et al. Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. J Am Coll Cardiol 1984: 3(4): 1044–50
- Elkayam U, Weber L, McKay C, et al. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol 1985:56(8): 560–6
- Cobn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration cooperative study. N Engl J Med 1986: 314(24): 1547–52
- Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure: mechanisms of action and recent clinical developments. N Engl J Med 1986: 314(5): 290–9; 1986: 314(6): 349–58
- Mancini D. LeJemtel T. Sonnenblick E. Intravenous use of amrinone for the treatment of the falling heart. Am J Cardiol 1985: 56(3): 8–15B
- Massie B, Bourassa M, DiBianco R, et al. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial. Circulation 1985: 71(5): 963–71
- Simonton CA, Chatteijee K, Cody RJ, et al. Milrinone in congestive heart failure: acute and chronic hemodynamic and clinical evaluation. J Am Coll Cardiol 1985: 6(2): 453–9
- White HD, Ribeiro JP, Hartley LH, et al. Immediate effects of milrinone on metabolic and sympathetic responses to exercise in severe congestive heart failure. Am J Cardiol 1985: 56(1): 93–8